Xponential Fitness, Inc. (NYSE: XPOF), the franchisor behind Club Pilates, closed at $4.20 on October 22, 2026, while Fund 1 Investments sits at 19.88% total economic exposure, just under the 19.9% trigger of the poison pill the board adopted on October 13. Special-situations writer Dalius (@InvestSpecial) flagged the build-up on October 23 as part of his strategic-review case for a sale. The board's review with Jefferies is still open, but there is no deal, and 2026 profit guidance was cut in August.
This is journalism and commentary, not investment advice. We hold no position unless stated.
Key facts
- Ticker and exchange: Xponential Fitness, Inc., XPOF, NYSE; a boutique fitness franchisor whose main brand is Club Pilates.
- Situation type: strategic review plus activist accumulation; no offer has been announced.
- The stake: Fund 1 Investments reported 4,170,610 shares (9.9%) plus cash-settled swaps on 4,213,826 shares (9.98%) in its October 20 Schedule 13D/A.
- The pill: the rights plan triggers at 19.9%, counts derivatives, had an October 22, 2026 record date and expires October 11, 2027.
- The waiver: a September 28, 2026 letter agreement waives Delaware's Section 203 for Fund 1, which agreed to stay at or below 19.9% including derivatives.
- The business: Q2 2026 revenue fell 13% to $66.0 million, North America same-store sales fell 6.8%, and the 2026 adjusted EBITDA guide was cut to $91-97 million from $100-110 million.
- Leverage: $522.4 million of total long-term debt against $25.0 million of cash at June 30, 2026.
Is XPOF a good bet right now?
It is a bet on a sale, not on the current business. Two large holders and an open review with Jefferies make a transaction more plausible than it was a year ago.
The case against is just as concrete. Sales and same-store sales are falling, the debt is large relative to the equity, and a review that ends without a buyer would leave holders with a shrinking franchisor and its debt.
Why are investors bullish on Xponential Fitness?
- Club Pilates. Bulls argue the Pilates brand alone could be worth more than the whole company's enterprise value.
- Motivated holders. Voss Capital reported 16.2% in May 2026, and Fund 1 now has about 19.88% total exposure.
- Underwater buyers. Fund 1 paid about $25.85 million for its 4,170,610 shares, roughly $6.20 a share by our math from its August 13D, well above $4.20.
- A board signal. The pill release says the plan "will not prevent an acquisition" and that the review remains ongoing.
Who's making this call and why?
Dalius runs a special-situations site and a paid picks service. On October 23 he posted: "Total economic exposure now stands at 19.88%." He tied it to his public April 23 Quick Pitch, headlined "Strategic review: 50% upside (at $6.88)."
That pitch valued Club Pilates at 11-13 times about $100 million of EBITDA, or $1.1-1.3 billion, against an enterprise value of about $910 million at the time. The stock has fallen about 39% from that $6.88 reference.
Fund 1 has done this before. In December 2024 it made a non-binding $3.00 cash proposal for Destination XL, a 34% premium at the time.
Track record. In our tracking, Dalius is 4-16 (a .200 win rate) on 20 calls scored at 180 days against the S&P 500, with an average edge of -11.7 points, ranked 10th. His March 9, 2026 XPOF long trailed the index by 31.5 points at 180 days. See the scoreboard.
Other supporters:
- FRAGMENTS Value, a small deep-value account, wrote on September 20: "At around $3.65, XPOF is getting very interesting."
- Event-driven monitor KEDM.com said on October 21, after the Fund 1 news: "Just sell the damn thing."
Who disagrees?
The sharpest caution came from a supporter. In an August 24 post, FRAGMENTS Value estimated about $2.92 per economic unit at 7 times the $94 million EBITDA midpoint if no deal comes, and about $1.96 at 6.5 times. "So I am not looking at $5 and pretending the downside is protected by some huge pile of assets."
The company's own numbers make the bear case:
- Shrinking results. Q2 adjusted EBITDA fell to $21.9 million from $28.1 million, and the company posted a $4.8 million net loss.
- Debt. $522.4 million of long-term debt is large next to a stock at $4.20.
- The cap. Fund 1 agreed to vote shares above 9.9% in proportion with other holders, so its extra exposure buys economics, not control.
- No bid yet. The review began in April 2026 and has produced no announced offer.
What are the key facts to verify?
- Fund 1's October 20 13D/A for the 9.9% stake, the 9.98% swaps, and $5 puts on 2,500,000 shares that it says expired unexercised on October 16.
- The September 30 13D/A for the five-year letter agreement and voting limits.
- The rights plan release for the 19.9% trigger and $15.00 exercise price.
- The Q2 2026 results for revenue, same-store sales, guidance and debt.
What would prove it right or wrong?
Right: Xponential Fitness announces a sale or a Club Pilates separation at a price above where Fund 1 and Voss bought, or Fund 1 makes a public proposal as it did at Destination XL.
Wrong: the board ends the review with no deal, Q3 results show more same-store declines or another guidance cut, and XPOF trades on its debt load instead of on takeover hopes.
This is journalism and commentary, not investment advice. We hold no position unless stated.